KarenAgersborgNetWorth

Karen Agersborg biography

Karen A. Agersborg serves as Non-Executive Director of the Company. Dr Agersborg is a Board-Certified Endocrinologist in Pennsylvania, USA, currently serving as Clinical Endocrinologist at Easton Hospital, Steward Health, specialising in Endocrinology, Diabetes & Metabolism. Dr Agersborg had previously worked at Reading Hospital, West Reading and at Suburban Hospital, Norristown as Clinical Endocrinologist and served as Chief, Endocrinology, Diabetes, Metabolism at Chestnut Hill Hospital. Dr Agersborg had an extensive career in managing commercial sales & distribution at Wyeth Pharmaceuticals (formerly Ayerst Laboratories). Dr Agersborg has played an integral role in setting the CLINUVEL Group’s US commercial strategy, resulting in the US FDA’s approval of SCENESSE® in October 2019.

What is the salary of Karen Agersborg?

As the Non-Executive Director of Clinuvel Pharmaceuticals, the total compensation of Karen Agersborg at Clinuvel Pharmaceuticals is $67,917. There are 7 executives at Clinuvel Pharmaceuticals getting paid more, with Philippe Wolgen having the highest compensation of $3,374,740.

ncG1vNJzZmivkaG5rrXNnmWcp51kvLWvjpyjr6SpZLynssicnKtnYWx%2BcoGRcGakmaKau26txp6prJqfp7Q%3D